MedTrace Logo

Management of Telemedicine Monitoring of Patients With Chronic Heart Failure

NCT05885425 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-06-02

No results posted yet for this study

Summary

Objective: to evaluate the possibilities and effect of telemedicine monitoring and management of patients with CHF (compared to patients with CHF without intensive telemedicine monitoring) on quality of life, prognosis and the presence of complications and hospitalisations.

Patients with a stable form of congestive heart failure will be gradually included in the study. Half of them will be defined by random selection to intervention group. Parameters, that can be measured at home will be periodically telemedical monitored. In according with at home monitored data, the own physician will be able to intervene with change of medical treatment in the case of non-physiological deviations in order to improve the health status as well as the prognosis of the patient with CHF.

Conditions

  • Congestive Heart Failure Chronic

Interventions

BEHAVIORAL

Telemedicine correction of medical treatment

On the basis of telemedicine data, the doctor will remotely correct medical treatment by adjusting the dose or supplementing or by omitting the medicine in order to improve the state of health, or to alleviate the symptoms of the disease monitored by telemedicine

BEHAVIORAL

Education for proper lifestyle

Based on telemedicine data, the doctor can consider periodic education of the patient with the innervated group in order to improve lifestyle

Sponsors & Collaborators

  • Trnava University in Trnava

    lead OTHER

Principal Investigators

  • Eva Goncalvesova · National Institute of Vascular and Heart Diseases Bratislava

  • Fedor Lehocki · Slovak University of Technology in Bratislava

  • Jozef Benacka · Trnava University in Trnava

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-05-01
Completion
2024-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05885425 on ClinicalTrials.gov